Abstract The clustered regularly interspaced short palindromic repeats (CRISPR)-Cas gene editing technology has opened a new era of genome interrogation and genome engineering because of its ease operation and high efficiency.An increasing number of plant species have been subjected to site-directed gene editing through this technology.However, the application of CRISPR-Cas technology to medicinal plants is still Firms’ participation in the Swiss COVID-19 loan programme in the early stages.Here, we review the research history, structural characteristics, working mechanism and the latest derivatives of CRISPR-Cas technology, and discussed THE ECONOMIC ESSENCE OF THE PROCESS OF MONETIZATION AND ITS ROLE IN ENSURING ECONOMIC DEVELOPMENT AND STABILITY OF THE FINANCIAL SYSTEM their application in medicinal plants for the first time.
Furthermore, we creatively put forward the development direction of CRISPR technology applied to medicinal plant gene editing.The aim is to provide a reference for the application of this technology to genome functional studies, synthetic biology, genetic improvement, and germplasm innovation of medicinal plants.CRISPR-Cas is expected to revolutionize medicinal plant biotechnology in the near future.